Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Dupont

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Lung Cancer|November 20, 2003
Phase I/II trial of the safety and efficacy of AE-941 (Neovastat) in the treatment of non-small-cell lung cancerJean Latreille, Gerald Batist, Francis Laberge, et al.
Cancer Treatment and Research Communications|December 24, 2022
Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatmentEugénie Rigault, Benjamin Lacas, Olivier Glehen, et al.
Cancer Immunology, Immunotherapy : CII|September 4, 2007
Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomasFrancoise Bouet-Toussaint, Florian Cabillic, Olivier Toutirais, et al.
The Journal of Urology|September 18, 2007
Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941Bernard Escudier, Toni K Choueiri, Stéphane Oudard, et al.
Annals of Surgical Oncology|October 21, 2025
Treatment Intensification with Hepatic Arterial Infusion Chemotherapy in Patients with Liver-Only Colorectal Metastases Still Unresectable After Systemic Induction Chemotherapy: Exploratory Findings From a Prematurely Closed Multicenter Randomized Phase II Study: SULTAN UCGI 30/PRODIGE 53 (NCT03164655)Alice Boilève, Franck Audemar, Eric Dupont-Bierre, et al.
BMC Cancer|February 1, 2020
Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocolAlice Boilève, Aline Maillard, Mathilde Wagner, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2023
Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trialDavid Malka, Benjamin Verret, Matthieu Faron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effectsRichard Béliveau, Denis Gingras, Erwin A Kruger, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Lung Cancer|November 20, 2003
Phase I/II trial of the safety and efficacy of AE-941 (Neovastat) in the treatment of non-small-cell lung cancerJean Latreille, Gerald Batist, Francis Laberge, et al.
Cancer Treatment and Research Communications|December 24, 2022
Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatmentEugénie Rigault, Benjamin Lacas, Olivier Glehen, et al.
Cancer Immunology, Immunotherapy : CII|September 4, 2007
Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomasFrancoise Bouet-Toussaint, Florian Cabillic, Olivier Toutirais, et al.
The Journal of Urology|September 18, 2007
Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941Bernard Escudier, Toni K Choueiri, Stéphane Oudard, et al.
Annals of Surgical Oncology|October 21, 2025
Treatment Intensification with Hepatic Arterial Infusion Chemotherapy in Patients with Liver-Only Colorectal Metastases Still Unresectable After Systemic Induction Chemotherapy: Exploratory Findings From a Prematurely Closed Multicenter Randomized Phase II Study: SULTAN UCGI 30/PRODIGE 53 (NCT03164655)Alice Boilève, Franck Audemar, Eric Dupont-Bierre, et al.
BMC Cancer|February 1, 2020
Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocolAlice Boilève, Aline Maillard, Mathilde Wagner, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2023
Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trialDavid Malka, Benjamin Verret, Matthieu Faron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effectsRichard Béliveau, Denis Gingras, Erwin A Kruger, et al.
Pageof 2